ArticleACS medicinal chemistry letters2016

Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).

Alexander M Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.